Recent college grad and former Trump campaign volunteer Taylor Weyeneth is now an administrative leader in the White House drug policy office. His brief biography offers few clues that he would so quickly assume a leading role in the drug policy office, a job recently occupied by a lawyer and a veteran government official. The story of his appointment and remarkable rise provides insight into the Trump administration’s political appointments and the troubled state of the drug policy office. Trump has pledged to marshal federal government talent and resources to address the opioid crisis, but nearly a year after his inauguration, the drug policy office, known as ONDCP, lacks a permanent director. In addition to its responsibilities for coordinating drug programs at other federal agencies, ONDCP is supposed to produce the National Drug Control Strategy, an annual blueprint for drug policy.

Source: Washington Post January 14, 2018 01:18 UTC